T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
1stdibs.com
DIBS
$163M
| $711K | ﹤0.01% |
124,974
-11,126
| -8% | -$73.2K |
|
2052
Digi International
DGII
$3.23B
| $708K | ﹤0.01% |
29,237
+234
| +0.8% | +$5.07K |
|
2053
ARS Pharmaceuticals
SPRY
$606M
| $705K | ﹤0.01% |
166,200
-134,374
| -45% | -$469K |
|
2054
Opko Health
OPK
$1.04B
| $697K | ﹤0.01% |
275,601
+3,096
| +1% | +$9.03K |
|
2055
Transocean
RIG
$6.39B
| $697K | ﹤0.01% |
209,220
-6,700
| -3% | -$27.1K |
|
2056
First Busey Corp
BUSE
$2.58B
| $695K | ﹤0.01% |
30,426
+1,387
| +5% | +$32.2K |
|
|
DHIL
2057
DELISTED
Diamond Hill
DHIL
| $693K | ﹤0.01% |
3,991
+17
| +0.4% | +$3.02K |
|
2058
Kura Oncology
KURA
$896M
| $693K | ﹤0.01% |
37,796
+423
| +1% | +$6.08K |
|
|
CIO
2059
DELISTED
City Office REIT
CIO
| $692K | ﹤0.01% |
53,410
+281
| +0.5% | +$3.98K |
|
|
BBT
2060
Beacon Financial Corp
BBT
$2.71B
| $691K | ﹤0.01% |
27,903
-8,257
| -23% | -$214K |
|
2061
Gray Television
GTN
$520M
| $691K | ﹤0.01% |
40,894
-39,864
| -49% | -$775K |
|
|
EVBG
2062
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $691K | ﹤0.01% |
24,772
+3,439
| +16% | +$139K |
|
2063
Astrana Health
ASTH
$1.78B
| $689K | ﹤0.01% |
17,848
-438
| -2% | -$16.7K |
|
|
GTY
2064
Getty Realty Corp
GTY
$2.04B
| $682K | ﹤0.01% |
25,719
+294
| +1% | +$8K |
|
2065
Malibu Boats
MBUU
$576M
| $682K | ﹤0.01% |
12,934
+170
| +1% | +$9.23K |
|
2066
Tompkins Financial
TMP
$1.44B
| $682K | ﹤0.01% |
9,457
+505
| +6% | +$37.4K |
|
|
POLY
2067
DELISTED
Plantronics, Inc.
POLY
| $682K | ﹤0.01% |
17,187
-2,414
| -12% | -$95.8K |
|
2068
Magnite
MGNI
$3.53B
| $680K | ﹤0.01% |
76,622
+20,294
| +36% | +$217K |
|
2069
Dorian LPG
LPG
$1.91B
| $677K | ﹤0.01% |
44,567
+121
| +0.3% | +$1.92K |
|
2070
Hackett Group
HCKT
$278M
| $675K | ﹤0.01% |
35,607
+323
| +0.9% | +$6.95K |
|
|
LMST
2071
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
| $675K | ﹤0.01% |
36,666
-2,404
| -6% | -$48.6K |
|
2072
Laureate Education
LAUR
$5.1B
| $674K | ﹤0.01% |
58,213
+12,829
| +28% | +$152K |
|
2073
Asana
ASAN
$2.28B
| $669K | ﹤0.01% |
38,059
-1,698,860
| -98% | -$42.7M |
|
2074
German American Bancorp
GABC
$1.92B
| $669K | ﹤0.01% |
19,575
+411
| +2% | +$14.9K |
|
|
BRKL
2075
DELISTED
Brookline Bancorp
BRKL
| $668K | ﹤0.01% |
50,176
+448
| +0.9% | +$6.43K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.